US20040225250A1 - Internal shunt and method for treating glaucoma - Google Patents
Internal shunt and method for treating glaucoma Download PDFInfo
- Publication number
- US20040225250A1 US20040225250A1 US10/429,336 US42933603A US2004225250A1 US 20040225250 A1 US20040225250 A1 US 20040225250A1 US 42933603 A US42933603 A US 42933603A US 2004225250 A1 US2004225250 A1 US 2004225250A1
- Authority
- US
- United States
- Prior art keywords
- accordance
- shunt
- scleral
- hollow tube
- treating glaucoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
Definitions
- This invention pertains to a surgical treatment for glaucoma and, more particularly, to a new method and apparatus for surgically alleviating the intraocular pressure causing the glaucoma condition.
- Glaucoma is an eye condition in which the hydrostatic pressure within the eye is abnormally high, thereby resulting in damage to the optic nerve.
- treatments for the glaucoma condition that involve lowering the intraocular pressure, either by means of medication or surgery.
- Medicinal treatments either decrease the rate at which aqueous humor is pumped into the eye or improve the outflow of aqueous humor from the eye.
- the invention seeks to provide a surgical treatment and apparatus that will overcome the many problems associated with present-day surgical procedures.
- the current invention provides an indwelling shunt that diverts aqueous humor from the anterior chamber to the blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure of the glaucomatous eye.
- the indwelling shunt maintains the area of exposure of aqueous humor with the uvea by physically preventing scarring of the surrounding tissues.
- the method utilizes the normally occurring 25 mm Hg driving force of the protein colloid osmotic pressure of the blood to maximize the flow of aqueous humor out of the eye (Yablonski, M. E., J of Glaucoma , February 2003, 12(1):90-92).
- the present invention overcomes the two main objections of most of the current surgical approaches: (a) it requires no permanent transcleral route for the egress of aqueous humor from the eye, and (b) the success of the procedure is not as dependent on the individual healing properties of the eye as it is in other procedures. Therefore, the inventive technique not only works in younger eyes, but it also works in eyes of darkly pigmented individuals, and eyes of patients who have had previous surgery. In addition, the inventive procedure leaves no transcleral route in the eye, thus decreasing the susceptibility to endophthalmitis.
- Another related technique to that of the current invention is the procedure that sutures a collagen implant beneath the scleral flap into the bed of the deep sclerectomy (M. E. Karlen, E. Sanchez, C. C. Schnyder, M. Sickenberg, and A. Mermoud, Deep sclerectomy with collagen implant: medium term results, Br J Ophthalmol , January 1999, 83(1): 6 - 11 ).
- the method provides a non-penetrating deep sclerectomy wherein a collagen implant is placed between the overlying scleral flap and the underlying suprachoroidal space. No dilation of the canal of Schlemm is performed. No flow of aqueous humor into the uveal blood is suggested, and only two scleral flap sutures are used, which renders the scleral flap permeable to transcleral flow and creates a transcleral fistula.
- a surgical technique and apparatus are illustrated for alleviating the glaucoma condition.
- the current invention provides an indwelling shunt that diverts aqueous humor from the anterior chamber to the blood flowing in the choroidal and uveal tissues. This decreases the intra-ocular pressure.
- the indwelling shunt maintains the area of exposure of aqueous humor with the uvea by physically preventing scarring of the surrounding tissues.
- the method utilizes the 25 mm Hg driving force of the protein colloidal osmotic pressure of the blood to maximize the flow.
- FIGS. 1, 3, and 4 comprises the initial step of folding back a one-third scleral thickness scleral flap hinged at the peripheral cornea.
- a small cavity is generated, extending into the peripheral cornea, by the removal of deep scleral tissue (known as a deep sclerectomy), leaving a very thin, approximately 50 micron in thickness scleral bed (FIG. 4) over the underlying choroid.
- the suprachoroidal space is entered at the lateral edges of the scleral bed by cutting directly or at a laterally slanted angle.
- the shunt which can comprise a precut tube with polished edges, is placed one end permanently into the suprachoroidal space and the other in the scleral lake and is sutured into the overlying sclera.
- the precut tube can be delivered with sutures in place for ease of deployment.
- Other examples of structures that can function as a shunt in addition to a hollow tube include a solid section of material grooved to carry aqueous humor, or a structure of open cell foam or other porous material, and similar structures in each case made from biologically compatible materials.
- one end of the tube is in the suprachoroidal space and the other is in the scleral lake created by the deep sclerectomy. Then a trabeculectomy specimen is created, plus a peripheral iridectomy, as in a standard trabeculectomy.
- the scleral flap is turned back to its normal position resting on the deep scleral shelf and is sutured to the adjacent sclera with six to ten interrupted sutures to yield a tight closure.
- the shunt can be fabricated from silicone or other biocompatible materials. One or two such tubes can be placed on each lateral side of the deep sclerectomy.
- These tubes not only shunt aqueous humor from the scleral lake into the suprachoroidal space, they also help maintain the volume of the scleral lake by acting as a physical barrier between the overlying scleral flap and the underlying scleral bed.
- the scleral lake is smaller and is separated from the anterior chamber by an approximately 3 mm wide layer of full thickness sclera.
- a tunnel is created with a 23 gauge needle and one end of the tube is inserted through the tunnel into the anterior chamber.
- the other end of the tube is placed through an incision, at the posterior edge of the scleral bed, into the posterior suprachoroidal space where it is sutured to the overlying sclera. Then the scleral flap is tightly sutured back into place.
- structures that can function as a shunt in addition to a hollow tube include a solid section of material grooved to carry aqueous humor, or a structure of open cell foam or other porous material, and similar structures in each case made from biologically compatible materials.
- FIG. 1 illustrates a top, three-dimensional, perspective, enlarged view of a portion of the eye, shown in partial cut-away;
- FIG. 2 depicts a top, three-dimensional perspective view of the second type of internal tube shunt procedure, enlarged view of the portion of the eye, shown in partial cutaway;
- FIG. 3 shows a top view of the portion of the eye illustrated in FIG. 1;
- FIG. 4 illustrates a sectional view of the portion of the eye depicted in FIGS. 1 and 3.
- an indwelling shunt is placed in the eye of patients having glaucoma.
- the shunt diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by the blood flowing in the choroidal and uveal tissues. This decreases the intra-ocular pressure.
- the indwelling shunt maintains the area of exposure of aqueous humor with the uvea by physically preventing scarring of the surrounding tissues.
- the method utilizes the 25 mm Hg driving force of the protein colloidal osmotic pressure of the blood to drive aqueous humor into the blood.
- FIGS. 1 through 4 a portion of an eye is shown being surgically prepared with a hollow tube (indwelling shunt) 1 for the treatment of glaucoma.
- the hollow tube 1 has an interior open space 2 in which fluid (not shown) is transferred.
- the tube 1 diverts aqueous humor from the scleral lake 8 (FIG. 4) to the suprachoroidal space 12 , as best observed with reference to FIGS. 1 and 3.
- This shunting of the aqueous humor decreases the intra-ocular pressure.
- the indwelling shunt 1 maintains the area of exposure of aqueous humor with the uvea by physically preventing scarring of the surrounding tissues.
- the method utilizes the 25 mm Hg driving force of the protein colloidal osmotic pressure of the blood of the uveal blood vessels 14 to maximize the flow (Yablonski, ibid.).
- the method comprises the initial step of folding back the scleral flap 4 of the eye (FIG. 1).
- a small cavity, the deep scleral lake 8 is generated by the removal of tissue in the sclera 7 .
- the suprachoroidal space 12 a normally occurring potential space, is entered by cutting directly, or at a slanted angle through the scleral bed 9 .
- the shunt 1 which can comprise a precut tube with polished edges, is then inserted into the suprachoroidal space 12 and sutured by sutures 15 to the overlying sclera 7 therein, as best seen in FIGS. 1 and 2.
- the precut tube 1 can also contain sutures fabricated in place for ease of deployment.
- a trabeculectomy specimen 5 may be removed, thus creating a direct communication to the anterior chamber 21 (best seen in FIG. 4).
- a peripheral iridectomy 6 may be created in the iris 11 .
- the scleral flap 4 is then replaced, resting on the deep scleral shelf 3 where it is tightly sutured to the adjacent sclera 7 .
- the shunt 1 can be fabricated from silicone or other biocompatible materials. It can be seen, therefore, that this technique does not create a permanent cyclodialysis cleft and does not disinsert the ciliary body from the scleral spur.
- the internal tube shunt 1 of the present invention is inserted and sutured between the suprachoroidal space 12 and the deep scleral lake 8 generated by the surgical forming of a scleral flap 4 , and a deep sclerectomy starting 4.5 mm from the limbus and extending into the peripheral cornea 10 . Since the deep sclerectomy is about 1 mm smaller than the dimensions of the scleral flap 4 , a deep scleral ledge 3 approximately 0.5 mm in width is created on the lateral and posterior aspect of the deep scleral lake 8 .
- the shunt 1 of the present invention is illustrated passing from the anterior chamber 21 through the adjacent sclera 7 , through a posterior deep scleral lake 8 , and into the posterior suprachoroidal space 12 where it is sutured to the overlying sclera 7 .
- the deep scleral lake 8 is generated by forming a scleral flap 4 and deep sclerectomy similar to that of FIG. 1 but with an anterior end 3 mm posterior to the cornea 10 .
- the shunt 1 of the present invention is inserted and laterally sutured into the suprachoroidal space 12 on each side of the deep scleral lake 8 generated by forming a scleral flap 4 and a deep sclerectomy, with the scleral flap 4 sutured back into place over the ends of the tube shunts 1 . Also shown are the peripheral iridectomy 6 and the trabeculectomy site 5 .
- the shunt of this invention is seen in the deep scleral lake 8 between the overlying scleral flap 4 and the underlying scleral bed 9 . Also shown are the trabeculectomy site 5 and the peripheral iridectomy 6 .
- FIGS. 1, 3, and 4 show one possible incorporation of the invention where aqueous humor gains access to the shunt 1 via a trabeculectomy 5 between the anterior chamber 21 and the deep scleral lake 8 where one end of the tube 1 lies. From the deep scleral lake 8 , aqueous humor is shunted via the tube 1 to the suprachoroidal space 12 .
- FIG. 2 shows another possible incorporation of the invention in which aqueous humor is shunted directly by a tube 1 that passes from the anterior chamber 21 through the sclera 7 between the anterior chamber 21 and the deep sclerectomy space, and into the suprachoroidal space 12 at the posterior aspect of the deep sclerectomy where it is sutured to the overlying sclera 7 .
- the deep sclerectomy is smaller than the deep scleral lake 8 shown in FIGS. 1 and 4. Unlike the version in FIGS. 1 and 4 where the deep scleral lake 8 serves as the pool of aqueous humor which flows into the tube 1 , in the version of FIG. 2, the deep sclerectomy serves only to allow the surgeon access for insertion of the tube 1 into the anterior chamber 21 , anteriorly, and the suprachoroidal space 12 , posteriorly. After the tube 1 is in place, the scleral flap 4 is sutured to the adjacent sclera 7 and no permanent deep scleral lake 8 need persist.
Abstract
A surgical technique and device wherein an indwelling shunt is placed in the eye of a patient having glaucoma. The shunt diverts aqueous humor from a deep scleral lake or directly from the anterior chamber to the suprachoroidal space from which it is removed by blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure. The indwelling shunt maintains the area of exposure of aqueous humor with the uvea by physically preventing scarring of the surrounding tissues. The method utilizes the 25 mm Hg driving force of the protein colloidal osmotic pressure of the blood to maximize the flow.
Description
- This invention pertains to a surgical treatment for glaucoma and, more particularly, to a new method and apparatus for surgically alleviating the intraocular pressure causing the glaucoma condition.
- Glaucoma is an eye condition in which the hydrostatic pressure within the eye is abnormally high, thereby resulting in damage to the optic nerve. There are many treatments for the glaucoma condition that involve lowering the intraocular pressure, either by means of medication or surgery.
- Medicinal treatments either decrease the rate at which aqueous humor is pumped into the eye or improve the outflow of aqueous humor from the eye.
- There are three primary surgical methods for treating glaucoma. Presently, none of them are a complete answer to the problem:
- a) Cyclodestructive procedures damage the ciliary body of the eye and decrease the rate of aqueous humor production. The main problem is the extremely fine dividing line between too little and too much treatment. This treatment often does not work, or it works too well. When the surgery works too well, a hypotonous eye may develop in which the pressure is too low for normal ocular function and health.
- b) Laser therapy of the trabecular meshwork is used to decrease the resistance of outflow of aqueous humor into the Canal of Schlemm. The main problem with this procedure is that it only provides relief for about five years. Re-treatment is often unsuccessful because it may cause too much scarring of the outflow channels. Thus, this procedure can do more harm than good.
- c) Shunting of aqueous humor from the anterior chamber through the sclera to outside of the confines of the eye is the most common surgical procedure. Among the shunting procedures, the often-performed trabeculectomy is a type of filtering method. It allows aqueous humor to “filter” out of the eye. A channel is created from the anterior chamber under a scleral flap to the episcleral space. The main problem with this procedure is that the outcome depends on the individual healing properties of the eye in the post-operative period. Trabeculectomy is often much less successful in highly pigmented eyes and eyes with previous surgery, rubeosis, or chronic uveitis. To overcome this problem, several shunts have been devised to carry aqueous humor from the anterior chamber to the episcleral space. Scarring often occurs surrounding the exterior end when shunts are used. This renders the outcome unpredictable.
- Another problem with these types of surgical procedures is that the globe is left with a transcleral fistula. The fistula renders the eye susceptible to the ingress of organisms and intraocular infection. This condition is known as endophthalmitis and can be devastating to the eye, since the eye is not naturally designed to defend against this type of onslaught.
- The invention seeks to provide a surgical treatment and apparatus that will overcome the many problems associated with present-day surgical procedures.
- The current invention provides an indwelling shunt that diverts aqueous humor from the anterior chamber to the blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure of the glaucomatous eye. The indwelling shunt maintains the area of exposure of aqueous humor with the uvea by physically preventing scarring of the surrounding tissues. The method utilizes the normally occurring 25 mm Hg driving force of the protein colloid osmotic pressure of the blood to maximize the flow of aqueous humor out of the eye (Yablonski, M. E.,J of Glaucoma, February 2003, 12(1):90-92).
- One of the many problems that this inventive procedure overcomes is the normally low outflow of aqueous humor into the uveal blood caused by the normally low hydraulic permeability between the aqueous humor of the anterior chamber and the uveal blood vessels (Yablonski, ibid.). The internal tube shunt of this invention, however, greatly increases the hydraulic permeability between the aqueous humor and the uveal blood vessels, thus greatly increasing the magnitude of the outflow via this route.
- The present invention overcomes the two main objections of most of the current surgical approaches: (a) it requires no permanent transcleral route for the egress of aqueous humor from the eye, and (b) the success of the procedure is not as dependent on the individual healing properties of the eye as it is in other procedures. Therefore, the inventive technique not only works in younger eyes, but it also works in eyes of darkly pigmented individuals, and eyes of patients who have had previous surgery. In addition, the inventive procedure leaves no transcleral route in the eye, thus decreasing the susceptibility to endophthalmitis.
- In an article by Stegmann (1990), a procedure is described wherein a non-penetrating deep sclerectomy is performed. The procedure was called “viscocanulostomy” because a viscoelastic substance was injected into the cut ends of the canal of Schlemm after the canal was exposed. Like the present technique, Stegmann first created a thin scleral flap, then created a deep sclerectomy by removing the deep sclera, leaving only a thin layer of sclera of 50 to 100 microns in thickness overlying the choroidal tissue beneath.
- It should be observed that Stegmann sutured the overlying scleral flap very tightly, thereby eliminating a final transcleral route for aqueous humor drainage. This implied that the intended mechanism for aqueous humor egress was an intraocular shunt. The mechanism of action of the procedure was proposed by Stegmann to be the access of aqueous humor to the newly dilated canal of Schlemm, from which it flowed from the eye by the usual outflow routes. However, if this were the case, the outflow facility of the eyes should be increased, as measured by tonography. No studies have shown an increase in outflow facility after the viscocanulostomy is performed, despite a marked decrease in intraocular pressure.
- Another related technique to that of the current invention is the procedure that sutures a collagen implant beneath the scleral flap into the bed of the deep sclerectomy (M. E. Karlen, E. Sanchez, C. C. Schnyder, M. Sickenberg, and A. Mermoud, Deep sclerectomy with collagen implant: medium term results,Br J Ophthalmol, January 1999, 83(1):6-11). The method provides a non-penetrating deep sclerectomy wherein a collagen implant is placed between the overlying scleral flap and the underlying suprachoroidal space. No dilation of the canal of Schlemm is performed. No flow of aqueous humor into the uveal blood is suggested, and only two scleral flap sutures are used, which renders the scleral flap permeable to transcleral flow and creates a transcleral fistula.
- In U.S. Pat. No. 6,383,219, issued on May 7, 2002 to Telandro et al., a related non-penetrating deep sclerectomy is illustrated. The method uses an implant made of a cross-linked hydraluronic acid material, which is shaped like a polyhedron having at least five faces. The material is placed between the overlying scleral flap and the underlying suprachoroidal scleral bed. Unlike the current inventive method, this procedure does not propose that the aqueous humor flows mainly into the adjacent uveal blood in response to its protein colloid osmotic pressure. The use of only two sutures in the overlying scleral flap renders this flap permeable to transcleral flow, creating a transcleral fistula.
- The stated mechanism for relief in Telandro et al. is the high water content that acts like a wick, i.e., it transports the ocular fluids by capillary action. No mention is made of flow of aqueous humor into the uveal blood, and it is implied that the final destination of the flow of aqueous humor is across the overlying scleral flap into the episcleral space. This method is similar to a conventional trabeculectomy and other filtering procedures.
- Some internal shunts have previously been proposed. In U.S. Pat. No. 6,450,984, issued to Lynch and Brown on Sep. 17, 2002, a shunt is illustrated that shunts fluid from the anterior chamber. The shunt is placed under a scleral flap and into the open ends of the canal of Schlemm. This method requires normal drainage of aqueous humor from the canal of Schlemm into the episcleral veins. Since in open angle glaucoma, which is the most common type of glaucoma, flow through the canal of Schlemm is impaired, this technique appears flawed. To the best of knowledge and belief, no reports exist in the literature depicting the successful implementation of this technique.
- In U.S. Pat. No. 5,601,094, issued on Feb. 11, 1997 to Reiss, a shunt is described which causes flow of aqueous humor from the anterior chamber to the suprachoroidal space. Unlike the present invention, however, the shunt is exteriorized before it enters the supracharoidal space. This renders the eye susceptible to endopthalmitis. To the best of knowledge and belief, there have been no successful reports for this technique in the literature.
- In U.S. Pat. No. 4,521,210, issued on Jun. 4, 1985 to Wong, a shunt is illustrated that extends from the anterior chamber to the suprachoroidal space. The shunt is designed to create a permanent cyclodialysis cleft and shunt aqueous fluid to the supracharoidal space from the anterior chamber. The suprachroidal space is surgically entered and the ciliary body disinserted from the scleral spur. To the best of knowledge and belief, there have not been any reports in the literature of the success of this technique.
- In accordance with the present invention, a surgical technique and apparatus are illustrated for alleviating the glaucoma condition. The current invention provides an indwelling shunt that diverts aqueous humor from the anterior chamber to the blood flowing in the choroidal and uveal tissues. This decreases the intra-ocular pressure. The indwelling shunt maintains the area of exposure of aqueous humor with the uvea by physically preventing scarring of the surrounding tissues. The method utilizes the 25 mm Hg driving force of the protein colloidal osmotic pressure of the blood to maximize the flow.
- One method illustrated in FIGS. 1, 3, and4 comprises the initial step of folding back a one-third scleral thickness scleral flap hinged at the peripheral cornea. A small cavity is generated, extending into the peripheral cornea, by the removal of deep scleral tissue (known as a deep sclerectomy), leaving a very thin, approximately 50 micron in thickness scleral bed (FIG. 4) over the underlying choroid. The suprachoroidal space is entered at the lateral edges of the scleral bed by cutting directly or at a laterally slanted angle. The shunt, which can comprise a precut tube with polished edges, is placed one end permanently into the suprachoroidal space and the other in the scleral lake and is sutured into the overlying sclera. The precut tube can be delivered with sutures in place for ease of deployment. Other examples of structures that can function as a shunt in addition to a hollow tube include a solid section of material grooved to carry aqueous humor, or a structure of open cell foam or other porous material, and similar structures in each case made from biologically compatible materials.
- After suturing, one end of the tube is in the suprachoroidal space and the other is in the scleral lake created by the deep sclerectomy. Then a trabeculectomy specimen is created, plus a peripheral iridectomy, as in a standard trabeculectomy. The scleral flap is turned back to its normal position resting on the deep scleral shelf and is sutured to the adjacent sclera with six to ten interrupted sutures to yield a tight closure. The shunt can be fabricated from silicone or other biocompatible materials. One or two such tubes can be placed on each lateral side of the deep sclerectomy. These tubes not only shunt aqueous humor from the scleral lake into the suprachoroidal space, they also help maintain the volume of the scleral lake by acting as a physical barrier between the overlying scleral flap and the underlying scleral bed.
- In another version of this procedure (FIG. 2), the scleral lake is smaller and is separated from the anterior chamber by an approximately 3 mm wide layer of full thickness sclera. A tunnel is created with a 23 gauge needle and one end of the tube is inserted through the tunnel into the anterior chamber. The other end of the tube is placed through an incision, at the posterior edge of the scleral bed, into the posterior suprachoroidal space where it is sutured to the overlying sclera. Then the scleral flap is tightly sutured back into place. Other examples of structures that can function as a shunt in addition to a hollow tube include a solid section of material grooved to carry aqueous humor, or a structure of open cell foam or other porous material, and similar structures in each case made from biologically compatible materials.
- It is an object of this invention to provide an improved surgical technique and apparatus for treating glaucoma.
- It is another object of the present invention to provide both a surgical method and an apparatus that utilizes the uveal blood vessels to drain aqueous humor from the anterior chamber of the eye to decrease intra-ocular pressure in the treatment of glaucoma.
- A complete understanding of the present invention may be obtained by reference to the accompanying drawings, when considered in conjunction with the subsequent detailed description, in which:
- FIG. 1 illustrates a top, three-dimensional, perspective, enlarged view of a portion of the eye, shown in partial cut-away;
- FIG. 2 depicts a top, three-dimensional perspective view of the second type of internal tube shunt procedure, enlarged view of the portion of the eye, shown in partial cutaway;
- FIG. 3 shows a top view of the portion of the eye illustrated in FIG. 1; and
- FIG. 4 illustrates a sectional view of the portion of the eye depicted in FIGS. 1 and 3.
- For purposes of brevity and clarity, like components and elements of the apparatus of this invention will bear the same designations or numbering throughout the FIGURES.
- Generally speaking, a surgical technique and apparatus is described wherein an indwelling shunt is placed in the eye of patients having glaucoma. The shunt diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by the blood flowing in the choroidal and uveal tissues. This decreases the intra-ocular pressure. The indwelling shunt maintains the area of exposure of aqueous humor with the uvea by physically preventing scarring of the surrounding tissues. The method utilizes the 25 mm Hg driving force of the protein colloidal osmotic pressure of the blood to drive aqueous humor into the blood.
- In FIGS. 1 through 4, a portion of an eye is shown being surgically prepared with a hollow tube (indwelling shunt)1 for the treatment of glaucoma. The
hollow tube 1 has an interior open space 2 in which fluid (not shown) is transferred. Thetube 1 diverts aqueous humor from the scleral lake 8 (FIG. 4) to thesuprachoroidal space 12, as best observed with reference to FIGS. 1 and 3. This shunting of the aqueous humor decreases the intra-ocular pressure. Theindwelling shunt 1 maintains the area of exposure of aqueous humor with the uvea by physically preventing scarring of the surrounding tissues. The method utilizes the 25 mm Hg driving force of the protein colloidal osmotic pressure of the blood of theuveal blood vessels 14 to maximize the flow (Yablonski, ibid.). - The method comprises the initial step of folding back the
scleral flap 4 of the eye (FIG. 1). A small cavity, the deepscleral lake 8, is generated by the removal of tissue in thesclera 7. Thesuprachoroidal space 12, a normally occurring potential space, is entered by cutting directly, or at a slanted angle through the scleral bed 9. Theshunt 1, which can comprise a precut tube with polished edges, is then inserted into thesuprachoroidal space 12 and sutured bysutures 15 to theoverlying sclera 7 therein, as best seen in FIGS. 1 and 2. Theprecut tube 1 can also contain sutures fabricated in place for ease of deployment. - After suturing the
tube 1 in place, atrabeculectomy specimen 5 may be removed, thus creating a direct communication to the anterior chamber 21 (best seen in FIG. 4). Aperipheral iridectomy 6 may be created in theiris 11. Thescleral flap 4 is then replaced, resting on thedeep scleral shelf 3 where it is tightly sutured to theadjacent sclera 7. Theshunt 1 can be fabricated from silicone or other biocompatible materials. It can be seen, therefore, that this technique does not create a permanent cyclodialysis cleft and does not disinsert the ciliary body from the scleral spur. - Referring to FIG. 1, the
internal tube shunt 1 of the present invention is inserted and sutured between thesuprachoroidal space 12 and the deepscleral lake 8 generated by the surgical forming of ascleral flap 4, and a deep sclerectomy starting 4.5 mm from the limbus and extending into theperipheral cornea 10. Since the deep sclerectomy is about 1 mm smaller than the dimensions of thescleral flap 4, a deepscleral ledge 3 approximately 0.5 mm in width is created on the lateral and posterior aspect of the deepscleral lake 8. - Referring now to FIG. 2, the
shunt 1 of the present invention is illustrated passing from theanterior chamber 21 through theadjacent sclera 7, through a posterior deepscleral lake 8, and into the posteriorsuprachoroidal space 12 where it is sutured to theoverlying sclera 7. The deepscleral lake 8 is generated by forming ascleral flap 4 and deep sclerectomy similar to that of FIG. 1 but with ananterior end 3 mm posterior to thecornea 10. - Referring now to FIG. 3, the
shunt 1 of the present invention is inserted and laterally sutured into thesuprachoroidal space 12 on each side of the deepscleral lake 8 generated by forming ascleral flap 4 and a deep sclerectomy, with thescleral flap 4 sutured back into place over the ends of the tube shunts 1. Also shown are theperipheral iridectomy 6 and thetrabeculectomy site 5. - Referring to FIG. 4, the shunt of this invention is seen in the deep
scleral lake 8 between the overlyingscleral flap 4 and the underlying scleral bed 9. Also shown are thetrabeculectomy site 5 and theperipheral iridectomy 6. - FIGS. 1, 3, and4 show one possible incorporation of the invention where aqueous humor gains access to the
shunt 1 via atrabeculectomy 5 between theanterior chamber 21 and the deepscleral lake 8 where one end of thetube 1 lies. From the deepscleral lake 8, aqueous humor is shunted via thetube 1 to thesuprachoroidal space 12. - FIG. 2 shows another possible incorporation of the invention in which aqueous humor is shunted directly by a
tube 1 that passes from theanterior chamber 21 through thesclera 7 between theanterior chamber 21 and the deep sclerectomy space, and into thesuprachoroidal space 12 at the posterior aspect of the deep sclerectomy where it is sutured to theoverlying sclera 7. - In this version, the deep sclerectomy is smaller than the deep
scleral lake 8 shown in FIGS. 1 and 4. Unlike the version in FIGS. 1 and 4 where the deepscleral lake 8 serves as the pool of aqueous humor which flows into thetube 1, in the version of FIG. 2, the deep sclerectomy serves only to allow the surgeon access for insertion of thetube 1 into theanterior chamber 21, anteriorly, and thesuprachoroidal space 12, posteriorly. After thetube 1 is in place, thescleral flap 4 is sutured to theadjacent sclera 7 and no permanentdeep scleral lake 8 need persist. - Since other modifications and changes varied to fit particular operating requirements and environments will be apparent to those skilled in the art, the invention is not considered limited to the examples chosen for purposes of disclosure and covers all changes and modifications which do not constitute departures from the true spirit and scope of this invention.
- Having thus described the invention, what is desired to be protected by Letters Patent is presented in the subsequently appended claims.
Claims (32)
1. A method of surgically treating glaucoma, comprising the steps of:
a) placing a shunt below scleral tissue of an eye in order to divert aqueous humor from a scleral lake to a suprachoroidal space from which said aqueous humor is removed by blood flowing in choroidal and uveal tissues, whereby intra-ocular pressure is reduced;
b) maintaining an area of exposure of said aqueous humor with uveal tissue by physically preventing scarring of surrounding tissues; and
c) utilizing osmotic pressure of the blood to maximize flow of said aqueous humor from said scleral lake.
2. The method of surgically treating glaucoma in accordance with claim 1 , wherein said shunt comprises an indwelling shunt remaining within the confines of the globe of said eye.
3. The method of surgically treating glaucoma in accordance with claim 1 , wherein said shunt comprises a hollow tube.
4. The method of surgically treating glaucoma in accordance with claim 3 , wherein said hollow tube is precut prior to surgery.
5. The method of surgically treating glaucoma in accordance with claim 4 , wherein said hollow tube has polished edges.
6. The method of surgically treating glaucoma in accordance with claim 4 , wherein said hollow tube has an attached suture and needle for suturing said hollow tube to said scleral tissue.
7. The method of surgically treating glaucoma in accordance with claim 1 , wherein said shunt placing step (a) further comprises the step of inserting said shunt into a suprachoroidal space of said eye.
8. The method of surgically treating glaucoma in accordance with claim 1 , further comprising the step of:
d) suturing said shunt within said eye.
9. A method of surgically treating glaucoma, comprising the steps of:
a) creating a scleral flap in scleral tissue of an eye;
b) performing a deep sclerectomy creating a deep scleral lake;
c) placing a tube-like shunt in a space below said scleral flap;
d) diverting aqueous humor from said deep scleral lake to an adjacent suprachoroidal space;
e) utilizing osmotic pressure of the blood flowing in choroidal and uveal tissues to maximize flow of said aqueous humor from said deep scleral lake to said adjacent suprachoroidal space.
10. The method of treating glaucoma in accordance with claim 9 , further comprising the step of:
f) maintaining an area of exposure of said aqueous humor with uveal tissue, by physically preventing scarring of surrounding tissues.
11. The method of surgically treating glaucoma in accordance with claim 10 , wherein said hollow tube is precut prior to surgery.
12. The method of surgically treating glaucoma in accordance with claim 11 , wherein said tube-like shunt comprises a hollow tube with polished edges.
13. (canceled)
14. The method of surgically treating glaucoma in accordance with claim 12 , wherein said hollow tube has an attached sutures suture and needles.
15. The method of surgically treating glaucoma in accordance with claim 9 , wherein said placing a tube-like shunt step (c) further comprises the step of inserting said tube-like shunt into a suprachoroidal space of said eye.
16. The method of surgically treating glaucoma in accordance with claim 9 , further comprising the step of:
f) suturing said tube-like shunt within said eye.
17. A device for the surgical treatment of glaucoma comprising a longitudinal structure comprising biologically compatible material that shunts aqueous humor from a deep scleral lake to the adjacent suprachoroidal space.
18. The device in accordance with claim 17 , further comprising an internal shunt remaining within the confines of the globe of an eye.
19. The device in accordance with claim 18 , further comprising a hollow tube, precut prior to surgery, wherein said hollow tube has polished edges, and said hollow tube has an attached suture and needle at one end for suturing said hollow tube.
20. The device in accordance with claim 18 , further comprising a shunting structure wherein said structure is a grooved material, an open celled foam material, or a porous material.
21. A method of surgically treating glaucoma, comprising the steps of:
a) creating a posterior scleral flap in the scleral tissue of an eye;
b) creating a posterior deep sclerectomy beneath said posterior scleral flap;
c) placing the anterior end of a tube-like shunt in a space below said posterior scleral flap through said scleral tissue into an anterior chamber of said eye;
d) placing the posterior end of said tube-like shunt into a suprachoroidal space;
e) diverting aqueous humor directly from said anterior chamber to said suprachoroidal space via said tube-like shunt from said anterior chamber through said adjacent scleral tissue, under said posterior scleral flap into said suprachoroidal space; and
f) utilizing osmotic pressure of the blood to maximize the flow of said aqueous humor from said suprachoroidal space into blood flowing in choroidal and uveal tissues.
22. The method of treating glaucoma in accordance with claim 21 , further comprising the step of:
g) maintaining an area of exposure of said aqueous humor with said uveal tissue, by physically preventing scarring of surrounding tissues.
23. The method of surgically treating glaucoma in accordance with claim 21 , wherein said tube-like shunt comprises a hollow tube.
24. The method of surgically treating glaucoma in accordance with claim 23 , wherein said hollow tube is precut prior to surgery.
25. The method of surgically treating glaucoma in accordance with claim 24 , wherein said hollow tube has polished edges.
26. The method of surgically treating glaucoma in accordance with claim 25 , wherein said hollow tube has an attached suture and needle in the posterior end of said hollow tube for fixation to said scleral tissue overlying said hollow tube.
27. The method of surgically treating glaucoma in accordance with claim 21 , further comprising the step of:
g) suturing said tube-like shunt within said eye.
28. A device for the surgical treatment of glaucoma comprising a longitudinal structure composed of biologically compatible material that shunts aqueous humor from the anterior chamber through the sclera into the suprachoroidal space, without creating a permanent cyclodialysis cleft and without disinserting the ciliary body from a scleral spur.
29. The device in accordance with claim 28 , wherein said longitudinal structure comprises an internal shunt remaining within the confines of the globe of an eye.
30. The device in accordance with claim 29 , further comprising a hollow tube, precut prior to surgery, wherein said hollow tube has polished edges, and said hollow tube has an attached suture and needle at one end for suturing said hollow tube.
31. The device in accordance with claim 29 , further comprising a shunting structure wherein said structure is selected from the group: a grooved material, an open celled foam material, and a porous material.
32. The device in accordance with claim 31 wherein said structure is precut prior to surgery, and said structure has an attached suture and needle at one end for suturing said structure.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/429,336 US20040225250A1 (en) | 2003-05-05 | 2003-05-05 | Internal shunt and method for treating glaucoma |
US11/509,327 US20070149915A1 (en) | 2003-05-05 | 2006-08-23 | Internal shunt and method for treating glaucoma |
US12/711,201 US8444588B2 (en) | 2003-05-05 | 2010-02-23 | Internal shunt and method for treating glaucoma |
US13/897,313 US8945038B2 (en) | 2003-05-05 | 2013-05-17 | Internal shunt and method for treating glaucoma |
US14/610,197 US9844462B2 (en) | 2003-05-05 | 2015-01-30 | Internal shunt and method for treating glaucoma |
US15/843,703 US20180104103A1 (en) | 2003-05-05 | 2017-12-15 | Internal Shunt And Method For Treating Glaucoma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/429,336 US20040225250A1 (en) | 2003-05-05 | 2003-05-05 | Internal shunt and method for treating glaucoma |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/509,327 Continuation US20070149915A1 (en) | 2003-05-05 | 2006-08-23 | Internal shunt and method for treating glaucoma |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040225250A1 true US20040225250A1 (en) | 2004-11-11 |
Family
ID=33416020
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/429,336 Abandoned US20040225250A1 (en) | 2003-05-05 | 2003-05-05 | Internal shunt and method for treating glaucoma |
US11/509,327 Abandoned US20070149915A1 (en) | 2003-05-05 | 2006-08-23 | Internal shunt and method for treating glaucoma |
US12/711,201 Expired - Lifetime US8444588B2 (en) | 2003-05-05 | 2010-02-23 | Internal shunt and method for treating glaucoma |
US13/897,313 Expired - Lifetime US8945038B2 (en) | 2003-05-05 | 2013-05-17 | Internal shunt and method for treating glaucoma |
US14/610,197 Active 2024-05-24 US9844462B2 (en) | 2003-05-05 | 2015-01-30 | Internal shunt and method for treating glaucoma |
US15/843,703 Abandoned US20180104103A1 (en) | 2003-05-05 | 2017-12-15 | Internal Shunt And Method For Treating Glaucoma |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/509,327 Abandoned US20070149915A1 (en) | 2003-05-05 | 2006-08-23 | Internal shunt and method for treating glaucoma |
US12/711,201 Expired - Lifetime US8444588B2 (en) | 2003-05-05 | 2010-02-23 | Internal shunt and method for treating glaucoma |
US13/897,313 Expired - Lifetime US8945038B2 (en) | 2003-05-05 | 2013-05-17 | Internal shunt and method for treating glaucoma |
US14/610,197 Active 2024-05-24 US9844462B2 (en) | 2003-05-05 | 2015-01-30 | Internal shunt and method for treating glaucoma |
US15/843,703 Abandoned US20180104103A1 (en) | 2003-05-05 | 2017-12-15 | Internal Shunt And Method For Treating Glaucoma |
Country Status (1)
Country | Link |
---|---|
US (6) | US20040225250A1 (en) |
Cited By (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060069340A1 (en) * | 2003-06-16 | 2006-03-30 | Solx, Inc. | Shunt for the treatment of glaucoma |
US7207965B2 (en) | 2003-06-16 | 2007-04-24 | Solx, Inc. | Shunt for the treatment of glaucoma |
US20070118147A1 (en) * | 2002-03-15 | 2007-05-24 | Smedley Gregory T | Combined treatment for cataract and glaucoma treatment |
WO2007084582A2 (en) | 2006-01-17 | 2007-07-26 | Forsight Labs, Llc | Drug delivery treatment device |
US20070191863A1 (en) * | 2006-01-17 | 2007-08-16 | De Juan Eugene Jr | Glaucoma Treatment Device |
US7364564B2 (en) | 2004-03-02 | 2008-04-29 | Becton, Dickinson And Company | Implant having MEMS flow module with movable, flow-controlling baffle |
US20080200860A1 (en) * | 2001-04-07 | 2008-08-21 | Glaukos Corporation | System for treating ocular disorders and methods thereof |
US20090048614A1 (en) * | 2007-08-17 | 2009-02-19 | Ralph Gudladt | Vessel-loop and method of making same |
US7544176B2 (en) | 2005-06-21 | 2009-06-09 | Becton, Dickinson And Company | Glaucoma implant having MEMS flow module with flexing diaphragm for pressure regulation |
US7815592B2 (en) | 2003-11-14 | 2010-10-19 | Transcend Medical, Inc. | Ocular pressure regulation |
US20110144559A1 (en) * | 2009-06-16 | 2011-06-16 | Khalid Lafdi | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US8007459B2 (en) | 2002-09-21 | 2011-08-30 | Glaukos Corporation | Ocular implant with anchoring mechanism and multiple outlets |
DE202011050692U1 (en) | 2010-07-16 | 2011-09-26 | Toni Hoyer | Device for light simulation of biological tissue, in particular for the eye area |
US20110238075A1 (en) * | 2009-12-23 | 2011-09-29 | Luke Clauson | Drug delivery devices and methods |
US8109896B2 (en) | 2008-02-11 | 2012-02-07 | Optonol Ltd. | Devices and methods for opening fluid passageways |
US8118768B2 (en) | 2001-04-07 | 2012-02-21 | Dose Medical Corporation | Drug eluting ocular implant with anchor and methods thereof |
US8142364B2 (en) | 2001-05-02 | 2012-03-27 | Dose Medical Corporation | Method of monitoring intraocular pressure and treating an ocular disorder |
US8167939B2 (en) | 2009-01-28 | 2012-05-01 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8313454B2 (en) | 1997-11-20 | 2012-11-20 | Optonol Ltd. | Fluid drainage device, delivery device, and associated methods of use and manufacture |
US8348877B2 (en) | 2000-04-14 | 2013-01-08 | Dose Medical Corporation | Ocular implant with therapeutic agents and methods thereof |
US8506515B2 (en) | 2006-11-10 | 2013-08-13 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US8617139B2 (en) | 2008-06-25 | 2013-12-31 | Transcend Medical, Inc. | Ocular implant with shape change capabilities |
US8672870B2 (en) | 2007-07-17 | 2014-03-18 | Transcend Medical, Inc. | Ocular implant with hydrogel expansion capabilities |
US8758290B2 (en) | 2010-11-15 | 2014-06-24 | Aquesys, Inc. | Devices and methods for implanting a shunt in the suprachoroidal space |
US8852137B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for implanting a soft gel shunt in the suprachoroidal space |
US8945038B2 (en) | 2003-05-05 | 2015-02-03 | Transcend Medical, Inc. | Internal shunt and method for treating glaucoma |
US9095413B2 (en) | 2011-12-08 | 2015-08-04 | Aquesys, Inc. | Intraocular shunt manufacture |
US9125723B2 (en) | 2013-02-19 | 2015-09-08 | Aquesys, Inc. | Adjustable glaucoma implant |
US9155656B2 (en) | 2012-04-24 | 2015-10-13 | Transcend Medical, Inc. | Delivery system for ocular implant |
US9301875B2 (en) | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
US9480598B2 (en) | 2012-09-17 | 2016-11-01 | Novartis Ag | Expanding ocular implant devices and methods |
US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
US9763829B2 (en) | 2012-11-14 | 2017-09-19 | Novartis Ag | Flow promoting ocular implant |
US9987163B2 (en) | 2013-04-16 | 2018-06-05 | Novartis Ag | Device for dispensing intraocular substances |
US9993368B2 (en) | 2000-04-14 | 2018-06-12 | Glaukos Corporation | System and method for treating an ocular disorder |
US10085633B2 (en) | 2012-04-19 | 2018-10-02 | Novartis Ag | Direct visualization system for glaucoma treatment |
RU2668702C1 (en) * | 2018-01-19 | 2018-10-02 | Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации | Method of glaucoma surgical treatment |
US10159600B2 (en) | 2013-02-19 | 2018-12-25 | Aquesys, Inc. | Adjustable intraocular flow regulation |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
US10307292B2 (en) | 2011-07-18 | 2019-06-04 | Mor Research Applications Ltd | Device for adjusting the intraocular pressure |
US10813789B2 (en) | 2009-05-18 | 2020-10-27 | Dose Medical Corporation | Drug eluting ocular implant |
US20210030590A1 (en) * | 2018-02-22 | 2021-02-04 | Ivantis, Inc. | Ocular implant and delivery system |
US10959941B2 (en) | 2014-05-29 | 2021-03-30 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
US11318043B2 (en) | 2016-04-20 | 2022-05-03 | Dose Medical Corporation | Bioresorbable ocular drug delivery device |
US11363951B2 (en) | 2011-09-13 | 2022-06-21 | Glaukos Corporation | Intraocular physiological sensor |
US11559430B2 (en) | 2013-03-15 | 2023-01-24 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11938059B2 (en) | 2013-11-14 | 2024-03-26 | Aquesys, Inc. | Intraocular shunt insertion techniques |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090082862A1 (en) | 2007-09-24 | 2009-03-26 | Schieber Andrew T | Ocular Implant Architectures |
US8734377B2 (en) | 2007-09-24 | 2014-05-27 | Ivantis, Inc. | Ocular implants with asymmetric flexibility |
US20170360609A9 (en) | 2007-09-24 | 2017-12-21 | Ivantis, Inc. | Methods and devices for increasing aqueous humor outflow |
US8808222B2 (en) | 2007-11-20 | 2014-08-19 | Ivantis, Inc. | Methods and apparatus for delivering ocular implants into the eye |
AU2009221859B2 (en) | 2008-03-05 | 2013-04-18 | Alcon Inc. | Methods and apparatus for treating glaucoma |
CN102481404B (en) | 2009-07-09 | 2014-03-05 | 伊万提斯公司 | Ocular implants |
AU2010271274B2 (en) | 2009-07-09 | 2015-05-21 | Alcon Inc. | Single operator device for delivering an ocular implant |
JP2013508096A (en) | 2009-10-23 | 2013-03-07 | イバンティス インコーポレイテッド | Intraocular transplantation system and intraocular transplantation method |
WO2011163505A1 (en) | 2010-06-23 | 2011-12-29 | Ivantis, Inc. | Ocular implants deployed in schlemm's canal of the eye |
EP2517619B1 (en) | 2011-04-27 | 2013-05-22 | Istar Medical | Improvements in or relating to glaucoma management and treatment |
US8657776B2 (en) | 2011-06-14 | 2014-02-25 | Ivantis, Inc. | Ocular implants for delivery into the eye |
US8663150B2 (en) | 2011-12-19 | 2014-03-04 | Ivantis, Inc. | Delivering ocular implants into the eye |
US9358156B2 (en) | 2012-04-18 | 2016-06-07 | Invantis, Inc. | Ocular implants for delivery into an anterior chamber of the eye |
US10617558B2 (en) | 2012-11-28 | 2020-04-14 | Ivantis, Inc. | Apparatus for delivering ocular implants into an anterior chamber of the eye |
WO2016011056A1 (en) | 2014-07-14 | 2016-01-21 | Ivantis, Inc. | Ocular implant delivery system and method |
US9744076B2 (en) | 2015-03-16 | 2017-08-29 | Jeannette M. A. da Silva Curiel | Method and apparatus for inserting an implant in the cornea of the eye |
US10842916B2 (en) | 2015-06-24 | 2020-11-24 | Healionics Corporation | Injectable porous device for treatment of dry and wet age-related macular degeneration or diabetic retinopathy |
US9655778B2 (en) | 2015-07-13 | 2017-05-23 | Thomas D. Tyler | Position responsive flow adjusting implantable device and method |
CN108135470B (en) | 2015-08-14 | 2021-03-09 | 伊万提斯公司 | Ocular implant with pressure sensor and delivery system |
US10322029B2 (en) | 2015-09-22 | 2019-06-18 | Novartis Ag | Ocular implant container |
WO2017106517A1 (en) | 2015-12-15 | 2017-06-22 | Ivantis, Inc. | Ocular implant and delivery system |
RU2676967C2 (en) * | 2017-05-31 | 2019-01-11 | федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) | Method of glaucoma surgical treatment |
WO2020251629A1 (en) | 2019-06-14 | 2020-12-17 | Iantrek, Inc. | Implantable biologic stent and system for biologic material shaping and preparation in the treatment of glaucoma |
EP4274529A1 (en) | 2021-01-11 | 2023-11-15 | Alcon Inc. | Systems and methods for viscoelastic delivery |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4037604A (en) * | 1976-01-05 | 1977-07-26 | Newkirk John B | Artifical biological drainage device |
US4722724A (en) * | 1986-06-23 | 1988-02-02 | Stanley Schocket | Anterior chamber tube shunt to an encircling band, and related surgical procedure |
US4946436A (en) * | 1989-11-17 | 1990-08-07 | Smith Stewart G | Pressure-relieving device and process for implanting |
US5397300A (en) * | 1990-05-31 | 1995-03-14 | Iovision, Inc. | Glaucoma implant |
US5433701A (en) * | 1994-12-21 | 1995-07-18 | Rubinstein; Mark H. | Apparatus for reducing ocular pressure |
US5476445A (en) * | 1990-05-31 | 1995-12-19 | Iovision, Inc. | Glaucoma implant with a temporary flow restricting seal |
US5558629A (en) * | 1990-05-31 | 1996-09-24 | Iovision, Inc. | Glaucoma implant |
US5601094A (en) * | 1994-11-22 | 1997-02-11 | Reiss; George R. | Ophthalmic shunt |
US5882327A (en) * | 1997-04-17 | 1999-03-16 | Jacob; Jean T. | Long-term glaucoma drainage implant |
US6186974B1 (en) * | 1997-01-10 | 2001-02-13 | University College London And Moorfields Eye Hospital Nhs Trust | Device for use in the eye |
US6537568B2 (en) * | 1997-08-11 | 2003-03-25 | Allergan, Inc. | Implant device with a retinoid for improved biocompatibility |
US6544208B2 (en) * | 2000-12-29 | 2003-04-08 | C. Ross Ethier | Implantable shunt device |
US20030135149A1 (en) * | 2002-01-13 | 2003-07-17 | Cheryl Cullen | Sinus valved glaucoma shunt |
US6595945B2 (en) * | 2001-01-09 | 2003-07-22 | J. David Brown | Glaucoma treatment device and method |
US6626858B2 (en) * | 1999-04-26 | 2003-09-30 | Gmp Vision Solutions, Inc. | Shunt device and method for treating glaucoma |
US6699210B2 (en) * | 1999-04-27 | 2004-03-02 | The Arizona Board Of Regents | Glaucoma shunt and a method of making and surgically implanting the same |
Family Cites Families (223)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990670A (en) | 1957-03-07 | 1961-07-04 | North American Rayon Corp | Yarn crimping and texturing apparatus |
US3439675A (en) | 1966-06-14 | 1969-04-22 | Becton Dickinson Co | Deformable needle assembly |
CS152018B1 (en) | 1970-05-27 | 1973-12-19 | ||
US3915172A (en) | 1970-05-27 | 1975-10-28 | Ceskoslovenska Akademie Ved | Capillary drain for glaucoma |
US3788327A (en) * | 1971-03-30 | 1974-01-29 | H Donowitz | Surgical implant device |
US4402681A (en) | 1980-08-23 | 1983-09-06 | Haas Joseph S | Artificial implant valve for the regulation of intraocular pressure |
GB2101891A (en) | 1981-07-18 | 1983-01-26 | Anthony Christopher Be Molteno | Device for draining aqueous humour |
US4457757A (en) | 1981-07-20 | 1984-07-03 | Molteno Anthony C B | Device for draining aqueous humour |
US4554918A (en) | 1982-07-28 | 1985-11-26 | White Thomas C | Ocular pressure relief device |
FI67916C (en) | 1982-08-03 | 1985-06-10 | Tampella Oy Ab | ANORDNING FOER FOERHANDSFAESTNING AV EN STAOLVAJERBULT |
US4521210A (en) * | 1982-12-27 | 1985-06-04 | Wong Vernon G | Eye implant for relieving glaucoma, and device and method for use therewith |
US4787885A (en) | 1984-04-06 | 1988-11-29 | Binder Perry S | Hydrogel seton |
US4634418A (en) * | 1984-04-06 | 1987-01-06 | Binder Perry S | Hydrogel seton |
US4604087A (en) | 1985-02-26 | 1986-08-05 | Joseph Neil H | Aqueous humor drainage device |
EP0228185B1 (en) | 1985-11-27 | 1990-07-25 | Thomas C. White | Tissue-implantable fluid-dissipating device |
NZ215409A (en) * | 1986-03-07 | 1989-02-24 | Anthony Christopher Be Molteno | Implant for drainage of aqueous humour in glaucoma |
DE3788532T2 (en) * | 1986-03-31 | 1994-04-21 | Nec Corp | Radio transmission system with simplified error correction circuit and fast channel switching. |
US4826478A (en) * | 1986-06-23 | 1989-05-02 | Stanley Schocket | Anterior chamber tube shunt to an encircling band, and related surgical procedure |
US4863457A (en) | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
US4846172A (en) | 1987-05-26 | 1989-07-11 | Berlin Michael S | Laser-delivery eye-treatment method |
US4900300A (en) * | 1987-07-06 | 1990-02-13 | Lee David A | Surgical instrument |
US4886488A (en) | 1987-08-06 | 1989-12-12 | White Thomas C | Glaucoma drainage the lacrimal system and method |
CA1295907C (en) | 1987-08-06 | 1992-02-18 | Thomas C. White | Glaucoma drainage in the lacrimal system |
US4936825A (en) * | 1988-04-11 | 1990-06-26 | Ungerleider Bruce A | Method for reducing intraocular pressure caused by glaucoma |
US5071408A (en) | 1988-10-07 | 1991-12-10 | Ahmed Abdul Mateen | Medical valve |
SG49267A1 (en) | 1989-08-14 | 1998-05-18 | Photogenesis Inc | Surgical instrument and cell isolation and transplantation |
US5817075A (en) | 1989-08-14 | 1998-10-06 | Photogenesis, Inc. | Method for preparation and transplantation of planar implants and surgical instrument therefor |
US5749879A (en) | 1989-08-16 | 1998-05-12 | Medtronic, Inc. | Device or apparatus for manipulating matter |
USRE35390E (en) | 1989-11-17 | 1996-12-03 | Smith; Stewart G. | Pressure relieving device and process for implanting |
US5092837A (en) * | 1989-12-20 | 1992-03-03 | Robert Ritch | Method for the treatment of glaucoma |
US4968296A (en) | 1989-12-20 | 1990-11-06 | Robert Ritch | Transscleral drainage implant device for the treatment of glaucoma |
US5073163A (en) * | 1990-01-29 | 1991-12-17 | Lippman Myron E | Apparatus for treating glaucoma |
SE9000491L (en) | 1990-02-12 | 1991-08-13 | Atos Medical Ab | GLAUCOMA VALVE |
US5180362A (en) * | 1990-04-03 | 1993-01-19 | Worst J G F | Gonio seton |
RU2056818C1 (en) | 1990-04-28 | 1996-03-27 | Межотраслевой научно-технический комплекс "Микрохирургия глаза" | Device for strengthening erection |
US5041081A (en) | 1990-05-18 | 1991-08-20 | Odrich Ronald B | Ocular implant for controlling glaucoma |
US5127901A (en) | 1990-05-18 | 1992-07-07 | Odrich Ronald B | Implant with subconjunctival arch |
US6007511A (en) | 1991-05-08 | 1999-12-28 | Prywes; Arnold S. | Shunt valve and therapeutic delivery system for treatment of glaucoma and methods and apparatus for its installation |
US5300020A (en) * | 1991-05-31 | 1994-04-05 | Medflex Corporation | Surgically implantable device for glaucoma relief |
US5171213A (en) | 1991-08-14 | 1992-12-15 | Price Jr Francis W | Technique for fistulization of the eye and an eye filtration prosthesis useful therefor |
US5326345A (en) | 1991-08-14 | 1994-07-05 | Price Jr Francis W | Eye filtration prostheses |
US5346464A (en) | 1992-03-10 | 1994-09-13 | Camras Carl B | Method and apparatus for reducing intraocular pressure |
RU2018289C1 (en) | 1992-03-19 | 1994-08-30 | Межотраслевой научно-технический комплекс "Микрохирургия глаза" | Method of treatment of secondary glaucoma in children |
US5284476A (en) | 1992-03-20 | 1994-02-08 | Koch Paul S | Nuclear hydrolysis cannula |
WO1994002081A1 (en) | 1992-07-16 | 1994-02-03 | Wong Vernon G | Eye implant suitable for relief of glaucoma |
US5370607A (en) | 1992-10-28 | 1994-12-06 | Annuit Coeptis, Inc. | Glaucoma implant device and method for implanting same |
WO1994013234A1 (en) | 1992-12-17 | 1994-06-23 | Michael Andrew Coote | Implant device and method for treatment of glaucoma |
US5338291A (en) | 1993-02-03 | 1994-08-16 | Pudenz-Schulte Medical Research Corporation | Glaucoma shunt and method for draining aqueous humor |
US5342370A (en) | 1993-03-19 | 1994-08-30 | University Of Miami | Method and apparatus for implanting an artifical meshwork in glaucoma surgery |
FR2710269A1 (en) | 1993-09-22 | 1995-03-31 | Voir Vivre | Implantable device for the treatment of edemas. |
US5676944A (en) | 1993-10-06 | 1997-10-14 | The Regents Of The University Of California | Ocular therapy with homologous macrophages |
US5423777A (en) | 1993-10-27 | 1995-06-13 | Tajiri; Akira | Punctum plug |
US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
US5454746A (en) | 1994-01-06 | 1995-10-03 | Meccano, S.A. | Toy hand tool |
US5743868A (en) * | 1994-02-14 | 1998-04-28 | Brown; Reay H. | Corneal pressure-regulating implant device |
IL109499A (en) * | 1994-05-02 | 1998-01-04 | Univ Ramot | Implant device for draining excess intraocular fluid |
US6102045A (en) | 1994-07-22 | 2000-08-15 | Premier Laser Systems, Inc. | Method and apparatus for lowering the intraocular pressure of an eye |
US5704907A (en) * | 1994-07-22 | 1998-01-06 | Wound Healing Of Oklahoma | Method and apparatus for lowering the intraocular pressure of an eye |
RU2074687C1 (en) | 1994-08-10 | 1997-03-10 | Волгоградский филиал Межотраслевого научно-технического комплекса "Микрохирургия глаза" | Method to treat glaucoma |
RU2074686C1 (en) | 1994-08-10 | 1997-03-10 | Волгоградский филиал Межотраслевого научно-технического комплекса "Микрохирургия глаза" | Method to treat glaucoma |
US5725493A (en) * | 1994-12-12 | 1998-03-10 | Avery; Robert Logan | Intravitreal medicine delivery |
US5558630A (en) * | 1994-12-30 | 1996-09-24 | Fisher; Bret L. | Intrascleral implant and method for the regulation of intraocular pressure |
WO1996020742A1 (en) | 1995-01-06 | 1996-07-11 | Wong Vernon G | Improve eye implant for relief of glaucoma |
US5792075A (en) | 1995-04-11 | 1998-08-11 | Schneider (Europe) A.G. | Method and apparatus for extending the length of a guide wire |
US5626558A (en) * | 1995-05-05 | 1997-05-06 | Suson; John | Adjustable flow rate glaucoma shunt and method of using same |
IL113723A (en) | 1995-05-14 | 2002-11-10 | Optonol Ltd | Intraocular implant |
CN1124164C (en) | 1995-05-14 | 2003-10-15 | 奥普通诺尔有限公司 | Intraocular implant, delivery device, and method of implantation |
US5968058A (en) | 1996-03-27 | 1999-10-19 | Optonol Ltd. | Device for and method of implanting an intraocular implant |
US5758562A (en) * | 1995-10-11 | 1998-06-02 | Schneider (Usa) Inc. | Process for manufacturing braided composite prosthesis |
US5741292A (en) * | 1995-10-26 | 1998-04-21 | Eagle Vision | Punctum dilating and plug inserting instrument with push-button plug release |
US20040148022A1 (en) * | 1996-03-18 | 2004-07-29 | Eggleston Harry C. | Modular intraocular implant |
US6258083B1 (en) | 1996-03-29 | 2001-07-10 | Eclipse Surgical Technologies, Inc. | Viewing surgical scope for minimally invasive procedures |
US5807302A (en) | 1996-04-01 | 1998-09-15 | Wandel; Thaddeus | Treatment of glaucoma |
US6152918A (en) | 1996-04-05 | 2000-11-28 | Eclipse Surgical Technologies, Inc. | Laser device with auto-piercing tip for myocardial revascularization procedures |
US6786888B1 (en) | 1996-05-20 | 2004-09-07 | Medtronic Ave, Inc. | Low profile catheter for emboli protection |
US6142969A (en) | 1996-10-25 | 2000-11-07 | Anamed, Inc. | Sutureless implantable device and method for treatment of glaucoma |
US6007510A (en) | 1996-10-25 | 1999-12-28 | Anamed, Inc. | Implantable devices and methods for controlling the flow of fluids within the body |
US6881197B1 (en) | 1996-10-25 | 2005-04-19 | Anamed, Inc. | Sutureless implantable device and method for treatment of glaucoma |
US5807244A (en) | 1996-11-15 | 1998-09-15 | Barot; Jagdish Shantilal | Single use disposable iris retractor |
US5941250A (en) | 1996-11-21 | 1999-08-24 | University Of Louisville Research Foundation Inc. | Retinal tissue implantation method |
AUPO394496A0 (en) | 1996-11-29 | 1997-01-02 | Lions Eye Institute | Biological microfistula tube and implantation method and apparatus |
US6261256B1 (en) | 1996-12-20 | 2001-07-17 | Abdul Mateen Ahmed | Pocket medical valve & method |
US5713844A (en) * | 1997-01-10 | 1998-02-03 | Peyman; Gholam A. | Device and method for regulating intraocular pressure |
FR2759577B1 (en) * | 1997-02-17 | 1999-08-06 | Corneal Ind | DEEP SCLERECTOMY IMPLANT |
US5893837A (en) * | 1997-02-28 | 1999-04-13 | Staar Surgical Company, Inc. | Glaucoma drain implanting device and method |
US6050970A (en) * | 1997-05-08 | 2000-04-18 | Pharmacia & Upjohn Company | Method and apparatus for inserting a glaucoma implant in an anterior and posterior segment of the eye |
US5752928A (en) * | 1997-07-14 | 1998-05-19 | Rdo Medical, Inc. | Glaucoma pressure regulator |
EP0898947A3 (en) * | 1997-08-15 | 1999-09-08 | GRIESHABER & CO. AG SCHAFFHAUSEN | Method and apparatus to improve the outflow of the aqueous humor of an eye |
US8313454B2 (en) * | 1997-11-20 | 2012-11-20 | Optonol Ltd. | Fluid drainage device, delivery device, and associated methods of use and manufacture |
US6203513B1 (en) * | 1997-11-20 | 2001-03-20 | Optonol Ltd. | Flow regulating implant, method of manufacture, and delivery device |
US6050999A (en) | 1997-12-18 | 2000-04-18 | Keravision, Inc. | Corneal implant introducer and method of use |
US6077299A (en) * | 1998-06-22 | 2000-06-20 | Eyetronic, Llc | Non-invasively adjustable valve implant for the drainage of aqueous humor in glaucoma |
DE19840047B4 (en) | 1998-09-02 | 2004-07-08 | Neuhann, Thomas, Prof.Dr.med. | Device for the targeted improvement and / or permanent guarantee of the permeability for eye chamber water through the trabecular mechanism in the Schlemm's Canal |
US6264668B1 (en) | 1998-09-16 | 2001-07-24 | Arnold S. Prywes | Ophthalmologic instrument for producing a fistula in the sclera |
JP3316748B2 (en) | 1998-10-20 | 2002-08-19 | 株式会社村田製作所 | Electroless plating holder and electroless plating method |
US6270472B1 (en) | 1998-12-29 | 2001-08-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Apparatus and a method for automatically introducing implants into soft tissue with adjustable spacing |
US8702727B1 (en) | 1999-02-01 | 2014-04-22 | Hologic, Inc. | Delivery catheter with implant ejection mechanism |
FR2790173A1 (en) * | 1999-02-24 | 2000-08-25 | Canon Kk | DIGITAL SIGNAL TRANSFORMATION DEVICE AND METHOD |
US20050119601A9 (en) * | 1999-04-26 | 2005-06-02 | Lynch Mary G. | Shunt device and method for treating glaucoma |
US6558342B1 (en) * | 1999-06-02 | 2003-05-06 | Optonol Ltd. | Flow control device, introducer and method of implanting |
US6221078B1 (en) * | 1999-06-25 | 2001-04-24 | Stephen S. Bylsma | Surgical implantation apparatus |
US6699285B2 (en) | 1999-09-24 | 2004-03-02 | Scieran Technologies, Inc. | Eye endoplant for the reattachment of a retina |
AU8026600A (en) | 1999-10-15 | 2001-04-30 | Deschutes Medical Products, Inc. | Brachytherapy instrument and methods |
US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
EP1239774B1 (en) * | 1999-12-10 | 2005-09-07 | Iscience Corporation | Treatment of ocular disease |
RU2157678C1 (en) | 1999-12-22 | 2000-10-20 | Макашова Надежда Васильевна | Surgical method for treating the cases of glaucoma |
AU2626401A (en) * | 2000-01-03 | 2001-07-16 | Johns Hopkins University, The | Surgical devices and methods of use thereof for enhanced tactile perception |
US6726676B2 (en) | 2000-01-05 | 2004-04-27 | Grieshaber & Co. Ag Schaffhausen | Method of and device for improving the flow of aqueous humor within the eye |
US20050119737A1 (en) * | 2000-01-12 | 2005-06-02 | Bene Eric A. | Ocular implant and methods for making and using same |
US6589203B1 (en) | 2000-01-26 | 2003-07-08 | Peter Mitrev | Glaucoma drainage device implant |
US6375642B1 (en) * | 2000-02-15 | 2002-04-23 | Grieshaber & Co. Ag Schaffhausen | Method of and device for improving a drainage of aqueous humor within the eye |
US6471666B1 (en) | 2000-02-24 | 2002-10-29 | Steven A. Odrich | Injectable glaucoma device |
US6533768B1 (en) | 2000-04-14 | 2003-03-18 | The Regents Of The University Of California | Device for glaucoma treatment and methods thereof |
US20030060752A1 (en) * | 2000-04-14 | 2003-03-27 | Olav Bergheim | Glaucoma device and methods thereof |
US7708711B2 (en) | 2000-04-14 | 2010-05-04 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
US20040111050A1 (en) * | 2000-04-14 | 2004-06-10 | Gregory Smedley | Implantable ocular pump to reduce intraocular pressure |
US20020143284A1 (en) | 2001-04-03 | 2002-10-03 | Hosheng Tu | Drug-releasing trabecular implant for glaucoma treatment |
US20050049578A1 (en) * | 2000-04-14 | 2005-03-03 | Hosheng Tu | Implantable ocular pump to reduce intraocular pressure |
US6638239B1 (en) | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
US20050277864A1 (en) | 2000-04-14 | 2005-12-15 | David Haffner | Injectable gel implant for glaucoma treatment |
CA2446143C (en) * | 2000-05-19 | 2010-01-19 | Michael S. Berlin | Delivery system and method of use for the eye |
US6561974B1 (en) | 2000-05-31 | 2003-05-13 | Grieshaber & Co. Ag Schaffhausen | Device for use in a surgical procedure on an eye of a living being, and method of retracting the iris |
AU2001268253A1 (en) | 2000-06-19 | 2002-01-02 | Glaukos Corporation | Stented trabecular shunt and methods thereof |
US6699211B2 (en) * | 2000-08-22 | 2004-03-02 | James A. Savage | Method and apparatus for treatment of glaucoma |
DE10042310A1 (en) | 2000-08-29 | 2002-03-14 | Aixmed Ges Fuer Medizintechnik | Aqueous humor drainage device |
DE60135352D1 (en) * | 2000-08-30 | 2008-09-25 | Univ Johns Hopkins | DEVICE FOR INTRA-OCCULAR ACTIVE AGGREGATION |
FR2813521B1 (en) * | 2000-09-01 | 2003-06-13 | Ioltechnologie Production | GLAUCOME DRAIN |
US6730056B1 (en) * | 2000-09-21 | 2004-05-04 | Motorola, Inc. | Eye implant for treating glaucoma and method for manufacturing same |
US6962573B1 (en) | 2000-10-18 | 2005-11-08 | Wilcox Michael J | C-shaped cross section tubular ophthalmic implant for reduction of intraocular pressure in glaucomatous eyes and method of use |
GB0025611D0 (en) | 2000-10-19 | 2000-12-06 | Duckworth & Kent Ltd | Tablet inserters |
AU2001261262A1 (en) | 2000-11-01 | 2002-05-15 | Glaukos Corporation | Glaucoma treatment device |
US6881198B2 (en) | 2001-01-09 | 2005-04-19 | J. David Brown | Glaucoma treatment device and method |
AU2002243612A1 (en) | 2001-01-18 | 2002-07-30 | The Regents Of The University Of California | Minimally invasive glaucoma surgical instrument and method |
US6989007B2 (en) * | 2001-02-21 | 2006-01-24 | Solx, Inc. | Devices and techniques for treating glaucoma |
JP2002263124A (en) | 2001-03-12 | 2002-09-17 | Masashige Nakayama | Eye disease treating method for animal and artificial lachrymal duct used therefor |
EP1367968A4 (en) | 2001-03-16 | 2006-12-13 | Glaukos Corp | Applicator and methods for placing a trabecular shunt for glaucoma treatment |
US20030028228A1 (en) | 2001-03-30 | 2003-02-06 | Sand Bruce J. | Treatment of collagen |
ES2304438T3 (en) | 2001-04-07 | 2008-10-16 | Glaukos Corporation | GLAUCOMA STENT FOR THE TREATMENT OF GLAUCOMA. |
US6666841B2 (en) | 2001-05-02 | 2003-12-23 | Glaukos Corporation | Bifurcatable trabecular shunt for glaucoma treatment |
US6981958B1 (en) * | 2001-05-02 | 2006-01-03 | Glaukos Corporation | Implant with pressure sensor for glaucoma treatment |
US7488303B1 (en) * | 2002-09-21 | 2009-02-10 | Glaukos Corporation | Ocular implant with anchor and multiple openings |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
AT409586B (en) | 2001-04-26 | 2002-09-25 | Clemens Dr Vass | Implant draining aqueous humor from anterior chamber of eye into Schlemm's channel, includes fixation plate for stabilization on sclera |
WO2002102274A2 (en) | 2001-05-01 | 2002-12-27 | Glaukos Corporation | Glaucoma device and methods thereof |
US7678065B2 (en) * | 2001-05-02 | 2010-03-16 | Glaukos Corporation | Implant with intraocular pressure sensor for glaucoma treatment |
AU2002305400A1 (en) | 2001-05-03 | 2002-11-18 | Glaukos Corporation | Medical device and methods of use for glaucoma treatment |
US6648283B2 (en) | 2001-07-06 | 2003-11-18 | Joanne M. Chase | Adjustable ornament display apparatus |
KR20040024873A (en) | 2001-08-03 | 2004-03-22 | 글루코마 리서치 테크널러지스 인코포레이션 | Method and intra-sclera implant for treatment of glaucoma and presbyopia |
US6911016B2 (en) | 2001-08-06 | 2005-06-28 | Scimed Life Systems, Inc. | Guidewire extension system |
KR20040036912A (en) | 2001-08-16 | 2004-05-03 | 지엠피 비젼 솔루션즈 인코포레이티드 | Improved shunt device and method for treating glaucoma |
US7331984B2 (en) * | 2001-08-28 | 2008-02-19 | Glaukos Corporation | Glaucoma stent for treating glaucoma and methods of use |
JP2005501602A (en) * | 2001-08-29 | 2005-01-20 | カルバーリョ、リカルド エイ.ピー. デ | Sealable implantable device for unidirectional delivery of therapeutic agents to tissue |
US20030097151A1 (en) * | 2001-10-25 | 2003-05-22 | Smedley Gregory T. | Apparatus and mitochondrial treatment for glaucoma |
US7163543B2 (en) * | 2001-11-08 | 2007-01-16 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US20030093084A1 (en) | 2001-11-13 | 2003-05-15 | Optonol Ltd. | Delivery devices for flow regulating implants |
US6712843B2 (en) * | 2001-11-20 | 2004-03-30 | Scimed Life Systems, Inc | Stent with differential lengthening/shortening members |
JP4303116B2 (en) | 2001-11-21 | 2009-07-29 | アイサイエンス コーポレイション | Ophthalmic microsurgery device |
WO2003073968A2 (en) | 2002-02-28 | 2003-09-12 | Gmp Vision Solutions, Inc. | Device and method for monitoring aqueous flow within the eye |
US20060200113A1 (en) | 2002-03-07 | 2006-09-07 | David Haffner | Liquid jet for glaucoma treatment |
US7186232B1 (en) * | 2002-03-07 | 2007-03-06 | Glaukoa Corporation | Fluid infusion methods for glaucoma treatment |
US7951155B2 (en) * | 2002-03-15 | 2011-05-31 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US20030229303A1 (en) | 2002-03-22 | 2003-12-11 | Haffner David S. | Expandable glaucoma implant and methods of use |
US9301875B2 (en) | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
US20040147870A1 (en) | 2002-04-08 | 2004-07-29 | Burns Thomas W. | Glaucoma treatment kit |
US20040024345A1 (en) * | 2002-04-19 | 2004-02-05 | Morteza Gharib | Glaucoma implant with valveless flow bias |
US20050085892A1 (en) | 2002-05-01 | 2005-04-21 | Olympus Corporation | Stent delivery device |
AU2003233300A1 (en) | 2002-05-29 | 2003-12-12 | University Of Saskatchewan Technologies Inc. | A shunt and method treatment of glaucoma |
US20030236483A1 (en) | 2002-06-25 | 2003-12-25 | Ren David H | Dual drainage ocular shunt for glaucoma |
ES2320121T3 (en) * | 2002-07-19 | 2009-05-19 | Yale University | UVEOESCLERAL DRAINAGE DEVICE. |
JP4258657B2 (en) | 2002-08-08 | 2009-04-30 | グローコス コーポレーション | Implantable eye pump to reduce intraocular pressure |
US7192412B1 (en) * | 2002-09-14 | 2007-03-20 | Glaukos Corporation | Targeted stent placement and multi-stent therapy |
AU2003273339B2 (en) | 2002-09-17 | 2008-08-14 | Iscience Interventional Corporation | Apparatus and method for surgical bypass of aqueous humor |
PL223153B1 (en) | 2002-09-18 | 2016-10-31 | Allergan Inc | Methods and apparatus for delivery of ocular implants |
WO2004043231A2 (en) | 2002-11-06 | 2004-05-27 | Gmp Vision Solutions, Inc. | Storage apparatus for surgical implant device |
US7160264B2 (en) | 2002-12-19 | 2007-01-09 | Medtronic-Xomed, Inc. | Article and method for ocular aqueous drainage |
JP2004208898A (en) | 2002-12-27 | 2004-07-29 | Japan Science & Technology Agency | Hydatoid discharging implant for glaucoma treatment |
WO2004062469A2 (en) | 2003-01-13 | 2004-07-29 | Clarity Corporation | Sinus valved glaucoma shunt |
US20040216749A1 (en) | 2003-01-23 | 2004-11-04 | Hosheng Tu | Vasomodulation during glaucoma surgery |
EP1596902B1 (en) | 2003-02-18 | 2017-07-05 | Hampar Karageozian | Device for draining fluids and lowering intraocular pressure |
US20040193262A1 (en) | 2003-03-29 | 2004-09-30 | Shadduck John H. | Implants for treating ocular hypertension, methods of use and methods of fabrication |
US20040193095A1 (en) | 2003-03-29 | 2004-09-30 | Shadduck John H. | Implants for treating ocular hypertension, methods of use and methods of fabrication |
US8404269B2 (en) * | 2003-04-11 | 2013-03-26 | Michael Snyder | Sustained release implantable eye device |
US20040225250A1 (en) | 2003-05-05 | 2004-11-11 | Michael Yablonski | Internal shunt and method for treating glaucoma |
US20040236343A1 (en) | 2003-05-23 | 2004-11-25 | Taylor Jon B. | Insertion tool for ocular implant and method for using same |
JP2007526013A (en) | 2003-06-16 | 2007-09-13 | ソルクス インコーポレイテッド | Shunt device for treating glaucoma |
US20060069340A1 (en) * | 2003-06-16 | 2006-03-30 | Solx, Inc. | Shunt for the treatment of glaucoma |
JP2007516740A (en) | 2003-11-10 | 2007-06-28 | アンジオテック インターナショナル アーゲー | Medical implants and scarring inhibitors |
US7291125B2 (en) | 2003-11-14 | 2007-11-06 | Transcend Medical, Inc. | Ocular pressure regulation |
JP5090742B2 (en) | 2003-12-05 | 2012-12-05 | インフォーカス リミテッド ライアビリティー カンパニー | Improved glaucoma transplant device |
US20050250788A1 (en) | 2004-01-30 | 2005-11-10 | Hosheng Tu | Aqueous outflow enhancement with vasodilated aqueous cavity |
US20060036207A1 (en) * | 2004-02-24 | 2006-02-16 | Koonmen James P | System and method for treating glaucoma |
US7364564B2 (en) | 2004-03-02 | 2008-04-29 | Becton, Dickinson And Company | Implant having MEMS flow module with movable, flow-controlling baffle |
US20050232972A1 (en) | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
JP2007534383A (en) | 2004-04-23 | 2007-11-29 | ジーエムピー ヴィジョン ソルーションズ インコーポレイテッド | Indwelling shunt device and device and method for glaucoma |
BRPI0510380A (en) | 2004-04-29 | 2007-11-06 | Iscience Surgical Corp | composite micro-cannula device, and methods for treating the supracoroidal space of an eye, for treating the posterior region of an eye and for treating tissues within or adjacent to the supracoroidal space of an eye |
BRPI0510433A (en) | 2004-04-29 | 2007-10-30 | Iscience Surgical Corp | apparatus for forming a tissue tract from within a first passage of an eye by connecting to a second passage in the eye, implant for placement in a surgically formed tissue tract, and method for creating a fluid path for aqueous humor of a eye |
US20050244462A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Devices and methods for treating a mammalian eye |
US7357778B2 (en) | 2004-05-20 | 2008-04-15 | Ajay Bhalla | Aqueous drainage and flow regulating implant |
US20050267398A1 (en) | 2004-05-27 | 2005-12-01 | Dimitri Protopsaltis | Glaucoma shunt |
US20050283108A1 (en) | 2004-06-10 | 2005-12-22 | Savage James A | Apparatus and method for non-pharmacological treatment of glaucoma and lowering intraocular pressure |
US7862531B2 (en) | 2004-06-25 | 2011-01-04 | Optonol Ltd. | Flow regulating implants |
US7717875B2 (en) | 2004-07-20 | 2010-05-18 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Steerable catheter with hydraulic or pneumatic actuator |
US7117870B2 (en) * | 2004-07-26 | 2006-10-10 | Clarity Corporation | Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same |
US20060032507A1 (en) * | 2004-08-11 | 2006-02-16 | Hosheng Tu | Contrast-enhanced ocular imaging |
US20060173397A1 (en) | 2004-11-23 | 2006-08-03 | Hosheng Tu | Ophthalmology implants and methods of manufacture |
US20120010702A1 (en) * | 2004-12-16 | 2012-01-12 | Iscience Interventional Corporation | Ophthalmic implant for treatment of glaucoma |
WO2007035895A2 (en) * | 2005-09-21 | 2007-03-29 | Cook Incorporated | Endoluminal stent graft delivery assembly |
EP3005996B1 (en) | 2006-01-17 | 2019-12-04 | Novartis Ag | Glaucoma treatment device |
CA2637602C (en) | 2006-01-17 | 2014-09-16 | Forsight Labs, Llc | Drug delivery treatment device |
EP3449873A1 (en) | 2006-03-31 | 2019-03-06 | Mati Therapeutics Inc. | Drug delivery structures and compositions for nasolacrimal system |
US20070293807A1 (en) | 2006-05-01 | 2007-12-20 | Lynch Mary G | Dual drainage pathway shunt device and method for treating glaucoma |
CA2668954C (en) | 2006-11-10 | 2020-09-08 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
EP2173289A4 (en) | 2007-07-17 | 2010-11-24 | Transcend Medical Inc | Ocular implant with hydrogel expansion capabilities |
US8617139B2 (en) | 2008-06-25 | 2013-12-31 | Transcend Medical, Inc. | Ocular implant with shape change capabilities |
US8377122B2 (en) | 2009-01-28 | 2013-02-19 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
WO2010115101A1 (en) | 2009-04-03 | 2010-10-07 | Transcend Medical, Inc. | Ocular implant delivery systems and methods |
US8535333B2 (en) | 2009-07-29 | 2013-09-17 | Transcend Medical, Inc. | Ocular implant applier and methods of use |
US20110118835A1 (en) | 2009-08-13 | 2011-05-19 | Matthew Silvestrini | Branched ocular implant |
US20110105990A1 (en) | 2009-11-04 | 2011-05-05 | Silvestrini Thomas A | Zonal drug delivery device and method |
US8529492B2 (en) | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
US8545430B2 (en) | 2010-06-09 | 2013-10-01 | Transcend Medical, Inc. | Expandable ocular devices |
US8444589B2 (en) | 2010-06-09 | 2013-05-21 | Transcend Medical, Inc. | Ocular implant with fluid outflow pathways having microporous membranes |
-
2003
- 2003-05-05 US US10/429,336 patent/US20040225250A1/en not_active Abandoned
-
2006
- 2006-08-23 US US11/509,327 patent/US20070149915A1/en not_active Abandoned
-
2010
- 2010-02-23 US US12/711,201 patent/US8444588B2/en not_active Expired - Lifetime
-
2013
- 2013-05-17 US US13/897,313 patent/US8945038B2/en not_active Expired - Lifetime
-
2015
- 2015-01-30 US US14/610,197 patent/US9844462B2/en active Active
-
2017
- 2017-12-15 US US15/843,703 patent/US20180104103A1/en not_active Abandoned
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4037604A (en) * | 1976-01-05 | 1977-07-26 | Newkirk John B | Artifical biological drainage device |
US4722724A (en) * | 1986-06-23 | 1988-02-02 | Stanley Schocket | Anterior chamber tube shunt to an encircling band, and related surgical procedure |
US4946436A (en) * | 1989-11-17 | 1990-08-07 | Smith Stewart G | Pressure-relieving device and process for implanting |
US5397300A (en) * | 1990-05-31 | 1995-03-14 | Iovision, Inc. | Glaucoma implant |
US5476445A (en) * | 1990-05-31 | 1995-12-19 | Iovision, Inc. | Glaucoma implant with a temporary flow restricting seal |
US5558629A (en) * | 1990-05-31 | 1996-09-24 | Iovision, Inc. | Glaucoma implant |
US5601094A (en) * | 1994-11-22 | 1997-02-11 | Reiss; George R. | Ophthalmic shunt |
US5433701A (en) * | 1994-12-21 | 1995-07-18 | Rubinstein; Mark H. | Apparatus for reducing ocular pressure |
US6186974B1 (en) * | 1997-01-10 | 2001-02-13 | University College London And Moorfields Eye Hospital Nhs Trust | Device for use in the eye |
US5882327A (en) * | 1997-04-17 | 1999-03-16 | Jacob; Jean T. | Long-term glaucoma drainage implant |
US6537568B2 (en) * | 1997-08-11 | 2003-03-25 | Allergan, Inc. | Implant device with a retinoid for improved biocompatibility |
US6626858B2 (en) * | 1999-04-26 | 2003-09-30 | Gmp Vision Solutions, Inc. | Shunt device and method for treating glaucoma |
US6699210B2 (en) * | 1999-04-27 | 2004-03-02 | The Arizona Board Of Regents | Glaucoma shunt and a method of making and surgically implanting the same |
US6544208B2 (en) * | 2000-12-29 | 2003-04-08 | C. Ross Ethier | Implantable shunt device |
US6595945B2 (en) * | 2001-01-09 | 2003-07-22 | J. David Brown | Glaucoma treatment device and method |
US20030135149A1 (en) * | 2002-01-13 | 2003-07-17 | Cheryl Cullen | Sinus valved glaucoma shunt |
Cited By (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8313454B2 (en) | 1997-11-20 | 2012-11-20 | Optonol Ltd. | Fluid drainage device, delivery device, and associated methods of use and manufacture |
US9789001B2 (en) | 2000-04-14 | 2017-10-17 | Dose Medical Corporation | Ocular implant with therapeutic agents and methods thereof |
US8348877B2 (en) | 2000-04-14 | 2013-01-08 | Dose Medical Corporation | Ocular implant with therapeutic agents and methods thereof |
US9066782B2 (en) | 2000-04-14 | 2015-06-30 | Dose Medical Corporation | Ocular implant with therapeutic agents and methods thereof |
US9993368B2 (en) | 2000-04-14 | 2018-06-12 | Glaukos Corporation | System and method for treating an ocular disorder |
US10485702B2 (en) | 2000-04-14 | 2019-11-26 | Glaukos Corporation | System and method for treating an ocular disorder |
US10828473B2 (en) | 2001-04-07 | 2020-11-10 | Glaukos Corporation | Ocular implant delivery system and methods thereof |
US9572963B2 (en) | 2001-04-07 | 2017-02-21 | Glaukos Corporation | Ocular disorder treatment methods and systems |
US8579846B2 (en) | 2001-04-07 | 2013-11-12 | Glaukos Corporation | Ocular implant systems |
US8075511B2 (en) | 2001-04-07 | 2011-12-13 | Glaukos Corporation | System for treating ocular disorders and methods thereof |
US8118768B2 (en) | 2001-04-07 | 2012-02-21 | Dose Medical Corporation | Drug eluting ocular implant with anchor and methods thereof |
US7857782B2 (en) | 2001-04-07 | 2010-12-28 | Glaukos Corporation | Ocular implant delivery system and method thereof |
US20080200860A1 (en) * | 2001-04-07 | 2008-08-21 | Glaukos Corporation | System for treating ocular disorders and methods thereof |
US8062244B2 (en) | 2001-04-07 | 2011-11-22 | Glaukos Corporation | Self-trephining implant and methods thereof for treatment of ocular disorders |
US9987472B2 (en) | 2001-04-07 | 2018-06-05 | Glaukos Corporation | Ocular implant delivery systems |
US9155654B2 (en) | 2001-04-07 | 2015-10-13 | Glaukos Corporation | Ocular system with anchoring implant and therapeutic agent |
US8142364B2 (en) | 2001-05-02 | 2012-03-27 | Dose Medical Corporation | Method of monitoring intraocular pressure and treating an ocular disorder |
US20070118147A1 (en) * | 2002-03-15 | 2007-05-24 | Smedley Gregory T | Combined treatment for cataract and glaucoma treatment |
US7951155B2 (en) | 2002-03-15 | 2011-05-31 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US8882781B2 (en) | 2002-03-15 | 2014-11-11 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US9301875B2 (en) | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
US8007459B2 (en) | 2002-09-21 | 2011-08-30 | Glaukos Corporation | Ocular implant with anchoring mechanism and multiple outlets |
US8945038B2 (en) | 2003-05-05 | 2015-02-03 | Transcend Medical, Inc. | Internal shunt and method for treating glaucoma |
US9844462B2 (en) | 2003-05-05 | 2017-12-19 | Novartis Ag | Internal shunt and method for treating glaucoma |
US7207965B2 (en) | 2003-06-16 | 2007-04-24 | Solx, Inc. | Shunt for the treatment of glaucoma |
US20060069340A1 (en) * | 2003-06-16 | 2006-03-30 | Solx, Inc. | Shunt for the treatment of glaucoma |
US7850638B2 (en) | 2003-11-14 | 2010-12-14 | Transcend Medical, Inc. | Ocular pressure regulation |
US8728021B2 (en) | 2003-11-14 | 2014-05-20 | Transcend Medical, Inc. | Ocular pressure regulation |
US10226380B2 (en) | 2003-11-14 | 2019-03-12 | Novartis Ag | Ocular pressure regulation |
US8128588B2 (en) | 2003-11-14 | 2012-03-06 | Transcend Medical, Inc. | Ocular pressure regulation |
US9351873B2 (en) | 2003-11-14 | 2016-05-31 | Transcend Medical, Inc. | Ocular pressure regulation |
US8486000B2 (en) | 2003-11-14 | 2013-07-16 | Transcend Medical, Inc. | Ocular pressure regulation |
US7815592B2 (en) | 2003-11-14 | 2010-10-19 | Transcend Medical, Inc. | Ocular pressure regulation |
US8808220B2 (en) | 2003-11-14 | 2014-08-19 | Transcend Medical, Inc. | Ocular pressure regulation |
US8771218B2 (en) | 2003-11-14 | 2014-07-08 | Transcend Medical, Inc. | Ocular pressure regulation |
US8758289B2 (en) | 2003-11-14 | 2014-06-24 | Transcend Medical, Inc. | Ocular pressure regulation |
US7364564B2 (en) | 2004-03-02 | 2008-04-29 | Becton, Dickinson And Company | Implant having MEMS flow module with movable, flow-controlling baffle |
US7544176B2 (en) | 2005-06-21 | 2009-06-09 | Becton, Dickinson And Company | Glaucoma implant having MEMS flow module with flexing diaphragm for pressure regulation |
US8734378B2 (en) | 2006-01-17 | 2014-05-27 | Transcend Medical, Inc. | Glaucoma treatment device |
US8721656B2 (en) * | 2006-01-17 | 2014-05-13 | Transcend Medical, Inc. | Glaucoma treatment device |
US11786402B2 (en) | 2006-01-17 | 2023-10-17 | Alcon Inc. | Glaucoma treatment device |
EP3338743A1 (en) | 2006-01-17 | 2018-06-27 | Novartis Ag | Drug delivery treatment device |
EP3005996A1 (en) | 2006-01-17 | 2016-04-13 | Transcend Medical, Inc. | Glaucoma treatment device |
WO2007084582A2 (en) | 2006-01-17 | 2007-07-26 | Forsight Labs, Llc | Drug delivery treatment device |
US20070191863A1 (en) * | 2006-01-17 | 2007-08-16 | De Juan Eugene Jr | Glaucoma Treatment Device |
US9421130B2 (en) | 2006-01-17 | 2016-08-23 | Novartis Ag. | Glaucoma treatment device |
US8801649B2 (en) | 2006-01-17 | 2014-08-12 | Transcend Medical, Inc. | Glaucoma treatment device |
EP3838236A1 (en) | 2006-01-17 | 2021-06-23 | Alcon Inc. | Glaucoma treatment device |
US8814819B2 (en) | 2006-01-17 | 2014-08-26 | Transcend Medical, Inc. | Glaucoma treatment device |
EP3632385A1 (en) | 2006-01-17 | 2020-04-08 | Novartis AG | Glaucoma treatment device |
US10905590B2 (en) | 2006-01-17 | 2021-02-02 | Alcon Inc. | Glaucoma treatment device |
US9398977B2 (en) | 2006-01-17 | 2016-07-26 | Transcend Medical, Inc. | Glaucoma treatment device |
US9789000B2 (en) | 2006-01-17 | 2017-10-17 | Novartis Ag | Glaucoma treatment device |
EP2526910A1 (en) | 2006-01-17 | 2012-11-28 | Transcend Medical, Inc. | Glaucoma treatment device |
US9084662B2 (en) | 2006-01-17 | 2015-07-21 | Transcend Medical, Inc. | Drug delivery treatment device |
US9668917B2 (en) | 2006-01-17 | 2017-06-06 | Novartis Ag | Drug delivery treatment device |
US8506515B2 (en) | 2006-11-10 | 2013-08-13 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US10828195B2 (en) | 2006-11-10 | 2020-11-10 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US9962290B2 (en) | 2006-11-10 | 2018-05-08 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US9585789B2 (en) | 2007-07-17 | 2017-03-07 | Novartis Ag | Ocular implant with hydrogel expansion capabilities |
US8672870B2 (en) | 2007-07-17 | 2014-03-18 | Transcend Medical, Inc. | Ocular implant with hydrogel expansion capabilities |
US7897090B2 (en) | 2007-08-17 | 2011-03-01 | Johnson & Johnson Medical Gmbh | Method for forming a vessel-loop |
US20090048614A1 (en) * | 2007-08-17 | 2009-02-19 | Ralph Gudladt | Vessel-loop and method of making same |
US8109896B2 (en) | 2008-02-11 | 2012-02-07 | Optonol Ltd. | Devices and methods for opening fluid passageways |
US10016301B2 (en) | 2008-06-25 | 2018-07-10 | Novartis Ag | Ocular implant with shape change capabilities |
US8617139B2 (en) | 2008-06-25 | 2013-12-31 | Transcend Medical, Inc. | Ocular implant with shape change capabilities |
US8167939B2 (en) | 2009-01-28 | 2012-05-01 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US11344448B2 (en) | 2009-01-28 | 2022-05-31 | Alcon Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8172899B2 (en) | 2009-01-28 | 2012-05-08 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8574294B2 (en) | 2009-01-28 | 2013-11-05 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8377122B2 (en) | 2009-01-28 | 2013-02-19 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US8262726B2 (en) | 2009-01-28 | 2012-09-11 | Transcend Medical, Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US10531983B2 (en) | 2009-01-28 | 2020-01-14 | Novartis Ag | Ocular implant with stiffness qualities, methods of implantation and system |
US11839571B2 (en) | 2009-01-28 | 2023-12-12 | Alcon Inc. | Ocular implant with stiffness qualities, methods of implantation and system |
US9763828B2 (en) | 2009-01-28 | 2017-09-19 | Novartis Ag | Ocular implant with stiffness qualities, methods of implantation and system |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US10813789B2 (en) | 2009-05-18 | 2020-10-27 | Dose Medical Corporation | Drug eluting ocular implant |
US11426306B2 (en) | 2009-05-18 | 2022-08-30 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
US20110144559A1 (en) * | 2009-06-16 | 2011-06-16 | Khalid Lafdi | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US20140248454A1 (en) * | 2009-06-16 | 2014-09-04 | Mobius Therapeutics, Llc | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US10137226B2 (en) * | 2009-06-16 | 2018-11-27 | Mobius Therapeutics, Llc | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US8764696B2 (en) * | 2009-06-16 | 2014-07-01 | Mobius Therapeutics, Inc. | Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts |
US9089392B2 (en) | 2009-12-23 | 2015-07-28 | Transcend Medical, Inc. | Drug delivery devices and methods |
US20110238075A1 (en) * | 2009-12-23 | 2011-09-29 | Luke Clauson | Drug delivery devices and methods |
US8529492B2 (en) * | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
US9549846B2 (en) | 2009-12-23 | 2017-01-24 | Novartis Ag | Drug delivery devices and methods |
US9173774B2 (en) | 2010-03-26 | 2015-11-03 | Optonol Ltd. | Fluid drainage device, delivery device, and associated methods of use and manufacture |
DE202011050692U1 (en) | 2010-07-16 | 2011-09-26 | Toni Hoyer | Device for light simulation of biological tissue, in particular for the eye area |
DE102011051741A1 (en) | 2010-07-16 | 2012-01-19 | Optitron Systems Gmbh | Device, particularly light eyeglasses for light stimulation of biological tissue, particularly for eye area of user, has unit which generates movable light point and another unit which provides breathing frequency for user |
US8852137B2 (en) | 2010-11-15 | 2014-10-07 | Aquesys, Inc. | Methods for implanting a soft gel shunt in the suprachoroidal space |
US8758290B2 (en) | 2010-11-15 | 2014-06-24 | Aquesys, Inc. | Devices and methods for implanting a shunt in the suprachoroidal space |
US10245178B1 (en) | 2011-06-07 | 2019-04-02 | Glaukos Corporation | Anterior chamber drug-eluting ocular implant |
US10307292B2 (en) | 2011-07-18 | 2019-06-04 | Mor Research Applications Ltd | Device for adjusting the intraocular pressure |
US11363951B2 (en) | 2011-09-13 | 2022-06-21 | Glaukos Corporation | Intraocular physiological sensor |
US9113994B2 (en) | 2011-12-08 | 2015-08-25 | Aquesys, Inc. | Intraocular shunt manufacture |
US9095413B2 (en) | 2011-12-08 | 2015-08-04 | Aquesys, Inc. | Intraocular shunt manufacture |
US9592154B2 (en) | 2011-12-08 | 2017-03-14 | Aquesys, Inc. | Intraocular shunt manufacture |
US10314743B2 (en) | 2011-12-08 | 2019-06-11 | Aquesys, Inc. | Intraocular shunt manufacture |
US10085633B2 (en) | 2012-04-19 | 2018-10-02 | Novartis Ag | Direct visualization system for glaucoma treatment |
US10912676B2 (en) | 2012-04-24 | 2021-02-09 | Alcon Inc. | Delivery system for ocular implant |
US9907697B2 (en) | 2012-04-24 | 2018-03-06 | Novartis Ag | Delivery system for ocular implant |
US9241832B2 (en) | 2012-04-24 | 2016-01-26 | Transcend Medical, Inc. | Delivery system for ocular implant |
US9155656B2 (en) | 2012-04-24 | 2015-10-13 | Transcend Medical, Inc. | Delivery system for ocular implant |
US9480598B2 (en) | 2012-09-17 | 2016-11-01 | Novartis Ag | Expanding ocular implant devices and methods |
US9763829B2 (en) | 2012-11-14 | 2017-09-19 | Novartis Ag | Flow promoting ocular implant |
US10195078B2 (en) | 2013-02-19 | 2019-02-05 | Aquesys, Inc. | Adjustable intraocular flow regulation |
US9125723B2 (en) | 2013-02-19 | 2015-09-08 | Aquesys, Inc. | Adjustable glaucoma implant |
US10195079B2 (en) | 2013-02-19 | 2019-02-05 | Aquesys, Inc. | Adjustable intraocular implant |
US10159600B2 (en) | 2013-02-19 | 2018-12-25 | Aquesys, Inc. | Adjustable intraocular flow regulation |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
US10849558B2 (en) | 2013-03-13 | 2020-12-01 | Glaukos Corporation | Intraocular physiological sensor |
US10285853B2 (en) | 2013-03-15 | 2019-05-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US11253394B2 (en) | 2013-03-15 | 2022-02-22 | Dose Medical Corporation | Controlled drug delivery ocular implants and methods of using same |
US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US11523938B2 (en) | 2013-03-15 | 2022-12-13 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US11559430B2 (en) | 2013-03-15 | 2023-01-24 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US10188551B2 (en) | 2013-03-15 | 2019-01-29 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US9987163B2 (en) | 2013-04-16 | 2018-06-05 | Novartis Ag | Device for dispensing intraocular substances |
US11938059B2 (en) | 2013-11-14 | 2024-03-26 | Aquesys, Inc. | Intraocular shunt insertion techniques |
US10959941B2 (en) | 2014-05-29 | 2021-03-30 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11318043B2 (en) | 2016-04-20 | 2022-05-03 | Dose Medical Corporation | Bioresorbable ocular drug delivery device |
RU2668702C1 (en) * | 2018-01-19 | 2018-10-02 | Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации | Method of glaucoma surgical treatment |
US20210030590A1 (en) * | 2018-02-22 | 2021-02-04 | Ivantis, Inc. | Ocular implant and delivery system |
Also Published As
Publication number | Publication date |
---|---|
US20100152641A1 (en) | 2010-06-17 |
US20150223982A1 (en) | 2015-08-13 |
US20180104103A1 (en) | 2018-04-19 |
US8444588B2 (en) | 2013-05-21 |
US20130253407A1 (en) | 2013-09-26 |
US8945038B2 (en) | 2015-02-03 |
US20070149915A1 (en) | 2007-06-28 |
US9844462B2 (en) | 2017-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9844462B2 (en) | Internal shunt and method for treating glaucoma | |
US10485702B2 (en) | System and method for treating an ocular disorder | |
EP0866680B1 (en) | Apparatus for lowering the intraocular pressure of an eye | |
US6102045A (en) | Method and apparatus for lowering the intraocular pressure of an eye | |
AU2001245698B2 (en) | Device for glaucoma treatment and methods thereof | |
US20210177657A1 (en) | Ocular device for treating glaucoma and related minimally invasive glaucoma surgery method | |
US20130281910A1 (en) | Ocular implant system | |
US20040015140A1 (en) | Uveoscleral drainage device | |
JP2002521145A (en) | Sutureless implantable devices and methods for treating glaucoma | |
US20190046356A1 (en) | Methods Materials Assemblies Apparatuses and Implants for Surgical Reduction of Intraocular Pressure to Suprachoidal Space Ab Externo and Subconjunctival Space | |
AU2012201744B8 (en) | Apparatus and method for treating ocular disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: YABLONSKI, JUDITH, OREGON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:YABLONSKI, MICHAEL (ANNE YABLONSKI SUISSE, EXECUTOR);REEL/FRAME:018001/0347 Effective date: 20060216 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: TRANSCEND MEDICAL INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:YABLONSKI, JUDITH;REEL/FRAME:019221/0367 Effective date: 20070418 |